Ignite Creation Date:
2025-12-24 @ 10:32 PM
Ignite Modification Date:
2026-02-26 @ 3:17 AM
Study NCT ID:
NCT06402435
Status:
RECRUITING
Last Update Posted:
2025-07-02
First Post:
2024-04-27
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
SBRT, Chemotherapy, and AK112 Neoadjuvant Therapy for Luminal-type Breast Cancer
Sponsor:
Hubei Cancer Hospital
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
HBCH-RT-2024-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None